Published in Blood Weekly, May 1st, 2008
"We welcome Dave's broad range of experience and success in our industry and are extremely happy to have him rejoin the Tengion Board of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.